Exercise Engagement in People Over 60 at Risk of Falls
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60-95
SponsorEast Lancashire Hospitals NHS Trust
About this trial
It is a qualitative study, using semi structured interviews to explore patient's experiences of falls and their perceptions on facilitators and barriers to exercise.
Aim: To explore reasons for and against engaging with exercises at home in participants over the age of 60 at risk of falls.
To explore:
1. Patients' preferences to exercise format and type eg/ leaflet, online, access, such as the Chartered Society of Physiotherapy (CSP) chair exercises leaflet or individual personalized rehabilitation programme handouts 2. The ability to discuss falls risk with health professionals. 3. If health inequalities exist with people at risk of falls and exercising. 4. Sustainability of exercise, in order to reduce the risk of falls in this population. 5. The need to develop MSK internal and external facing falls management pathways.
Suitability: Patients over the age of 60, who have been identified at risk of falls, having been referred to MSK Physiotherapy in Rossendale.
'Risk of falls' is defined as: patient self-reports they are unsteady, had one or more fall in the last 6 months, or clinician identified a slow/unsteady gait pattern on examination.
Semi structured interviews on up to ten participants. It is anticipated that this sample size will give adequate data saturation. Approximately 12 months from participant recruitment to analysis of findings.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged 60 years or over
At risk of falls or had a fall due to a musculoskeletal cause (pain, muscle weakness, balance issue)
Has capacity to consent, as deemed by the direct care team and researcher
Can communicate in English OR the use of a translation service - Able to independently participate in an interview either face-to-face or via remote means OR can use a translation service
Disqualifiers
Have a medical cause of falls OR currently under investigation for a medical cause of falls (eg/ dizziness, cardiac, visual impairment reported as being the cause of the fall as opposed to weakness or pain in lower limbs/balance issues or unsteady on feet)
Moderate to severe cognitive impairment impairing capacity to consent
Trial population
This is a single centre study, based at Rossendale Health Centre. The MSK Physiotherapy Service is part of an integrated model in East Lancashire Hospitals NHS Trust (ELHT) for managing musculoskeletal, rheumatology, orthopaedic and pain conditions (https://elht.nhs.uk/services/integrated-msk-pain-and-rheumatology-service). The aim is to deliver the highest quality of care and support for patients with musculoskeletal conditions. This includes patients who have been referred following falls resulting in fractures or soft tissue injuries, and painful long-term conditions such as osteoarthritis which can impact mobility. A third of the caseload in MSK physiotherapy consists of patients over the age of 60.
Trial design
Design model
Other
Time perspective
Other
Treatments tested in this trial
Semi structured interviews
BehavioralGaining qualitative data
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Explore reasons for and against engaging with exercises at home.
By identifying themes during anaylsis of study interviews
Time frame
Through study completion, an average of 1 yearSecondary outcomes
1
Patients' thoughts on service materials, provision and communication
Identify preferred exercise format and understanding of information eg/ leaflet, online, access, such as the Chartered Society of Physiotherapy (CSP) chair exercises leaflet or their own online personalised rehabilitation programme handouts by analysing themes of the interviews
Time frame
Through study completion, an average of 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
East Lancashire Hospitals NHS Trust
Lead sponsor
National Institute for Health Research, United Kingdom
Collaborator
Source ClinicalTrials.gov